期刊文献+

β受体阻滞剂在抗心律失常治疗中的应用优势 被引量:25

原文传递
导出
摘要 近年来随着β受体阻滞剂在心血管病治疗中的广泛应用,其在抗心律失常治疗上亦愈加受到重视,它是一种被证明为能降低心脏性猝死而降低总死亡率的抗心律失常药物,不仅在治疗高血压、心力衰竭、心肌梗死方面有其一定的地位,还在抗心律失常方面有其独特的作用.与传统的抗心律失常药物相比,第2代以索他洛尔、美托洛尔为代表及第3代以卡维地洛、拉贝洛尔为代表的β受体阻滞剂存在相当的优势,主要表现为其在心脏神经-电生理方面的影响较传统的抗快速性心律失常药物更为全面、安全.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第11期114-116,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献12

  • 1Xi Li,Tingzhong Wang,Ke Han,Xiaozhen Zhuo,Qun Lu,Aiqun Ma.Bisoprolol reverses down-regulation of potassium channel proteins in ventricular tissues of rabbits with heart failure[J].The Journal of Biomedical Research,2011,25(4):274-279. 被引量:6
  • 2李晓东,尹德录,叶琳,蒋文平.血管紧张素-(1-7)对心肌细胞L-型钙通道的影响[J].临床心血管病杂志,2003,19(11):674-676. 被引量:2
  • 3杨荣平.心肌M细胞的认识及其临床进展[J].岭南心血管病杂志,2002,8(5):367-367. 被引量:2
  • 4Konstantinos P. Letsas,Reinhold Weber,Klaus Astheimer.T-peak-T-end interval and T-peak-T-end/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype[].Europace.2010
  • 5Piepoli M F,Capucci A.Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification[].Minerva cardioangiologica.2007
  • 6S.G. Priori,E. Aliot,C. Blomstrom-Lundqvist,L. Bossaert,G. Breithardt,P. Brugada,A.J. Camm,R. Cappato,S.M. Cobbe,C. Di Mario,B.J. Maron,W.J. McKenna,A.K. Pedersen,U. Ravens,P.J. Schwartz,M. Trusz-Gluza,P. Vardas,H.J.J. We.Task Force on Sudden Cardiac Death of the European Society of Cardiology[].European Heart Journal.2001
  • 7WE Cascio.Myocardial ischemia: what factors determine arrhythmogenesis?[].Journal of Cardiology.2001
  • 8Zicha S,Tsuji Y,Shiroshita-Takeshita A,Nattel S.Beta-blockers as antiarrhythmic agents[].Handbook of experimental pharmacology.2006
  • 9Karle C A,Kreye V A,Thomas D,et al.Antiarrhythmic drug carvedilol inhibits HERG potassium channels[].Cardiovascular Research.2001
  • 10Cruickshank John M.Beta-blockers and heart failure[].Indian Heart Journal.2010

二级参考文献41

  • 1Brosnihan K B, Li P, Ferrario C M. Angiotensin-(1-7)dilates canine coronary arteries through kinin and nitric oxide. Hypertension, 1996,27:523-- 528.
  • 2Sun H, Leblanc N, Nattel S. Mechanisms of inactivation of L-type calcium channels in human artrial myocytes. Am J Physiol, 1997,273:H1625--H1635.
  • 3Nussberger J. Ang I and Ang II disappear completely from circulation blood within 48 hours after binephrectomy:improved measurement of angiotensin in rat plasma. J Hypertens, 1991,9:S230--S231.
  • 4Paula R D, Lima C V, Khosla M C, et al. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension, 1995,26 : 1154-- 1159.
  • 5Roks A J, Geel P P, Yigal M P. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension, 1999,34 : 269-- 301.
  • 6Drouin E, Charpentier F, Gauthier C,et al. Electrophysiological characteristics of cells spanning the left ventricularwall of human heart: evidence for presence of M cells. J Am Coll Cardiol, 1995, 26:185
  • 7Sicouri S, Antzelevitch C. A subpopulation of cells with unique electropysiological properties in the deep subepicardium of the canine ventricle: the M cell. Circ Res, 1991,68:1729~1741
  • 8Antzelevitch C, Sicouri C. Clinical relevance of cardiac arrhythmias generated by afterdepolarization: role of M cells in the generation of U waves triggered activity and torsade de points. J Am Coll Cardio, 1994, 23:259
  • 9Liu DW, Antzelevitch C. Characeristics of the delayed rectifier current(Ikr and Iks) in canine ventricular epicardial, midmyocardial, and endocardial myocytes: A weaker Iks contributes to the long action potential of the M cell.Circ Res, 1995, 76:351~364
  • 10Sicouri S, Fish J, Antzelevitch C.Ditribution of M cells in the canine ventricle. J Cardiovasc Electrophsiol,1994, 5:824~837

共引文献7

同被引文献166

引证文献25

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部